» Authors » Carol L Rosenberg

Carol L Rosenberg

Explore the profile of Carol L Rosenberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 723
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahern T, Christensen M, Cronin-Fenton D, Lunetta K, Soiland H, Gjerde J, et al.
Cancer Epidemiol Biomarkers Prev . 2011 Jul; 20(9):1937-43. PMID: 21750172
Background: Tamoxifen is oxidized by cytochrome-P450 enzymes (e.g., CYP2D6) to two active metabolites, which are eliminated via glucuronidation by UDP-glucuronosyl transferases (UGT). We measured the association between functional polymorphisms in...
2.
Fogh S, Hirsch A, Langmead J, Goldberg S, Rosenberg C, Taghian A, et al.
Clin Breast Cancer . 2011 Mar; 11(1):39-45. PMID: 21421521
Background: The purpose of this study is to assess the impact of adjuvant therapy on survival in males with non-metastatic breast cancer. Materials And Methods: A retrospective analysis of male...
3.
Hannafon B, Sebastiani P, de las Morenas A, Lu J, Rosenberg C
Breast Cancer Res . 2011 Mar; 13(2):R24. PMID: 21375733
Introduction: microRNA (miRNA) are short, noncoding RNA that negatively regulate gene expression and may play a causal role in invasive breast cancer. Since many genetic aberrations of invasive disease are...
4.
Lash T, Cronin-Fenton D, Ahern T, Rosenberg C, Lunetta K, Silliman R, et al.
J Natl Cancer Inst . 2011 Feb; 103(6):489-500. PMID: 21325141
Background: Cytochrome P450 2D6 (CYP2D6) inhibition reduces the concentration of 4-hydroxylated tamoxifen metabolites, but the clinical relevance remains uncertain. Methods: We conducted a large case-control study nested in the population...
5.
Ahern T, Christensen M, Cronin-Fenton D, Lunetta K, Rosenberg C, Sorensen H, et al.
Clin Epidemiol . 2010 Dec; 2:241-6. PMID: 21152250
Objectives: Translational epidemiology studies often use archived tumor specimens to evaluate genetic hypotheses involving cancer outcomes. When the exposure of interest is a germline polymorphism, a key concern is whether...
6.
Graham K, Ge X, de las Morenas A, Tripathi A, Rosenberg C
Clin Cancer Res . 2010 Nov; 17(2):236-46. PMID: 21059815
Purpose: Previously, we found that gene expression in histologically normal breast epithelium (NlEpi) from women at high breast cancer risk can resemble gene expression in NlEpi from cancer-containing breasts. Therefore,...
7.
Lash T, Cronin-Fenton D, Ahern T, Rosenberg C, Lunetta K, Silliman R, et al.
Acta Oncol . 2010 Feb; 49(3):305-12. PMID: 20156115
Background: Up to one-quarter of breast cancer patients suffer clinically significant depression in the year after diagnosis, which may respond to intervention. About half may be prescribed a psychotropic medication,...
8.
Lash T, Rosenberg C
J Clin Oncol . 2010 Feb; 28(8):1273-5. PMID: 20124162
No abstract available.
9.
Emery L, Tripathi A, King C, Kavanah M, Mendez J, Stone M, et al.
Am J Pathol . 2009 Aug; 175(3):1292-302. PMID: 19700746
Proliferative breast lesions, such as simple ductal hyperplasia (SH) and atypical ductal hyperplasia (ADH), are candidate precursors to ductal carcinoma in situ (DCIS) and invasive cancer. To better understand the...
10.
Stead L, Lash T, Sobieraj J, Chi D, Westrup J, Charlot M, et al.
Breast Cancer Res . 2009 Mar; 11(2):R18. PMID: 19320967
Introduction: We investigated clinical and pathologic features of breast cancers (BC) in an unselected series of patients diagnosed in a tertiary care hospital serving a diverse population. We focused on...